1. Home
  2. BW vs DBVT Comparison

BW vs DBVT Comparison

Compare BW & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Babcock & Wilcox Enterprises Inc.

BW

Babcock & Wilcox Enterprises Inc.

HOLD

Current Price

$5.25

Market Cap

544.4M

Sector

Industrials

ML Signal

HOLD

DBVT

DBV Technologies S.A.

HOLD

Current Price

$19.17

Market Cap

508.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BW
DBVT
Founded
1867
2002
Country
United States
France
Employees
N/A
N/A
Industry
Building Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
544.4M
508.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BW
DBVT
Price
$5.25
$19.17
Analyst Decision
Buy
Buy
Analyst Count
2
7
Target Price
$5.50
$31.75
AVG Volume (30 Days)
2.9M
767.2K
Earning Date
11-04-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$721,285,000.00
$5,502,000.00
Revenue This Year
N/A
$1,768.71
Revenue Next Year
$4.85
$1,028.88
P/E Ratio
N/A
N/A
Revenue Growth
80.30
N/A
52 Week Low
$0.22
$2.93
52 Week High
$7.77
$26.19

Technical Indicators

Market Signals
Indicator
BW
DBVT
Relative Strength Index (RSI) 47.27 56.61
Support Level $4.73 $18.46
Resistance Level $5.44 $22.89
Average True Range (ATR) 0.50 1.82
MACD -0.12 0.01
Stochastic Oscillator 36.34 41.17

Price Performance

Historical Comparison
BW
DBVT

About BW Babcock & Wilcox Enterprises Inc.

Babcock & Wilcox Enterprises Inc is a power generation equipment supplier and servicing company that operates in three segments: B&W Renewable, B&W Environmental, and B&W Thermal. B&W Thermal, focuses on steam generation products and solutions for plants in the power generation, oil, and gas, and industrial sectors, generates the majority of the company's revenue. B&W Renewable focuses on sustainable power and heat generation while B&W Environmental focuses on emissions control. The company's customer base spans the industrial, electrical utility, and municipal industries located predominantly in the United States, Canada, Denmark, the United Kingdom, and other regions. Business in the U.S. contributes the vast majority of its revenue.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: